ArticleOncotarget2016

Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.

Ayman A M Alameen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.